Quick verdict: BMA vs COLB in 2026

In this bma vs colb stock comparison 2026, Columbia Banking System, Inc. (COLB) generally holds a significant edge across key financial metrics, leading in growth, value, and profitability. While COLB demonstrates stronger fundamentals and analyst preference in terms of buy ratings, Banco Macro S.A. (BMA) presents a notably higher implied upside according to analyst price targets. Investors considering should i buy bma or colb stock 2026 must weigh COLB’s robust operational performance against BMA’s potential for significant price appreciation. Not investment advice.

BMA vs COLB: key metrics side by side

Full side-by-side comparison of BMA and COLB across valuation, profitability, growth and analyst sentiment. Data updated 2026-05-03.

BMA vs COLB valuation comparison

When examining the bma vs colb fundamentals and valuation, COLB appears significantly more attractive from a traditional valuation standpoint. Columbia Banking System, Inc. (COLB) trades at a P/E ratio of 13.12x and a P/B ratio of 1.12x, which are considerably lower than Banco Macro S.A. (BMA). BMA’s P/E stands at an elevated 43.02x, and its P/B ratio is an astonishing 1920.9x, suggesting extreme market optimism or unique accounting considerations for a bank.

Despite both stocks showing a negative DCF upside, indicating they might be overvalued relative to their discounted cash flow models, BMA’s DCF suggests it is -34.5% overvalued, while COLB is -43.2% overvalued. This implies BMA is slightly less overvalued according to its specific DCF model, but this insight must be balanced against its extremely high P/E and P/B ratios. For investors focused on conventional value metrics, COLB undeniably presents a much cheaper entry point compared to BMA in 2026.

BMA vs COLB growth comparison

In terms of revenue growth, Columbia Banking System, Inc. (COLB) demonstrates significantly stronger momentum compared to Banco Macro S.A. (BMA). COLB reported a positive year-over-year revenue growth of 8.3%, indicating healthy expansion in its operations. This contrasts sharply with BMA, which recorded a substantial negative revenue growth of -99.9%, signaling a near-complete contraction in its top line during the last reporting period.

This dramatic difference in revenue growth makes COLB the clear leader for growth-oriented investors. Further, COLB exhibits superior margins, with a gross margin of 68.98% versus BMA’s 61.1%, a net margin of 19.56% compared to BMA’s 4.07%, and an EBITDA margin of 29.58% against BMA’s 10.32%. These robust margins, combined with positive revenue growth, suggest a more efficient and expanding business for COLB, reinforcing its stronger momentum heading into 2026.

BMA vs COLB profitability

When analyzing profitability for BMA vs COLB, Columbia Banking System, Inc. (COLB) distinctly outperforms Banco Macro S.A. (BMA). COLB boasts a net margin of 19.56%, which is substantially higher than BMA’s 4.07%. This indicates that COLB is far more effective at converting its revenue into profit. Similarly, COLB’s EBITDA margin of 29.58% significantly surpasses BMA’s 10.32%, showcasing greater operational efficiency before interest, taxes, depreciation, and amortization.

Both companies have an “N/A%” reported for Return on Equity (ROE), preventing a direct comparison on this specific metric. However, COLB generates significantly more cash relative to its market capitalization, with a Free Cash Flow (FCF) yield of 10.29%, nearly double BMA’s FCF yield of 4.54%. This strong FCF yield, combined with its superior net and EBITDA margins, clearly establishes COLB as the more profitable and cash-generative enterprise of the two.

Analyst ratings: BMA vs COLB

Analyst sentiment provides a nuanced perspective on BMA vs COLB stock comparison 2026. For Banco Macro S.A. (BMA), 14 analysts cover the stock, with 42.9% issuing a “Buy” rating. The consensus target price for BMA is $130, implying a substantial upside of +88.8% from its current price of $68.86. This suggests that despite recent performance challenges, analysts see significant potential for BMA to appreciate in value. The FMP rating for BMA is A-, indicating a strong fundamental outlook.

Columbia Banking System, Inc. (COLB) is covered by a larger group of 19 analysts, and a higher percentage, 52.7%, currently recommend a “Buy”. The consensus target for COLB is $32.9, which represents a more modest, but still positive, upside of +11.3% from its current price of $29.56. While analysts have a higher “Buy” conviction rate for COLB, indicating a preference for its more stable and profitable profile, BMA’s considerably higher implied price target upside makes it the analysts’ pick for potential capital gains. COLB’s FMP rating is B+, slightly lower than BMA’s.

Should I buy BMA or COLB stock in 2026?

For growth investors looking to invest in 2026, Columbia Banking System, Inc. (COLB) appears to be the stronger contender. Its positive revenue growth of 8.3% stands in stark contrast to Banco Macro S.A.’s (BMA) severe -99.9% decline, indicating COLB has significantly better operational momentum. Furthermore, COLB’s superior profitability metrics, including much higher net and EBITDA margins, suggest a more efficient business capable of sustained expansion.

Value investors pondering should i buy bma or colb stock 2026 will likely find COLB more appealing based on traditional valuation multiples. COLB trades at a P/E of 13.12x and a P/B of 1.12x, which are considerably more attractive than BMA’s P/E of 43.02x and exceptionally high P/B of 1920.9x. While BMA’s DCF downside of -34.5% is technically less negative than COLB’s -43.2%, the extreme P/E and P/B ratios for BMA suggest it is priced for exceptional future performance that has yet to materialize, making COLB a safer bet for value.

Regarding income, both BMA and COLB offer an identical dividend yield of 0.05%. This very low yield means neither stock stands out as a strong income play for dividend-focused investors. Given the overall bma vs colb fundamentals and valuation, COLB generally presents a more robust profile with better growth, profitability, and more reasonable valuation multiples. This is not investment advice; always conduct your own thorough research.

More BMA and COLB comparisons

BMA full stock analysis · COLB full stock analysis · All stock comparisons

FAQ: BMA vs COLB